Every one of those 1 sits in a single category, pharma. Mojdeh Poul is most often covered alongside FDA, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Mojdeh Poul, all published on February 26, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Mojdeh Poul
Every one of those 1 sits in a single category, pharma. Mojdeh Poul is most often covered alongside FDA, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Mojdeh Poul, all published on February 26, 2026. Each carries 2 original sources on average.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 18 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Mojdeh Poul. Shared-story counts are live from our verified record — not editorial picks.
Integra LifeSciences reported its latest quarterly results, highlighting a period of strategic stabilization and operational remediation. While the company continues to address manufacturing challenges at its Boston facility, the appointment of new leadership and steady performance in its Codman Specialty Surgical segment signal a path toward long-term recovery.
Mojdeh Poul is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.